Ketamine-induced cholangiopathy in ARDS patients-Reference-Cited by-同舟云学术

Ketamine-induced cholangiopathy in ARDS patients

Published:2021-07-27 Issue:10 Volume:47 Page:1173-1174
ISSN:0342-4642
Container-title:Intensive Care Medicine
language:en
Short-container-title:Intensive Care Med

Author:

de Tymowski Christian,Dépret François^ORCID,Dudoignon Emmanuel,Legrand Matthieu,Mallet Vincent,Mallet Vincent,Bock Kilian,Mandengue Paul Doumbe,Dufour Nicolas,Ricard Jean-Damien,Isnard Pierre,Van Huyen Jean-Paul Duong,Correas Jean-Michel,Voigtländer Torsten,Frochot Vincent,Letavernier Emmanuel,Moga Lucile,Landrieux Amandine,Chouchana Laurent,Gernez Coralie,Burger Carole,Scemla Anne,Lamhaut Lionel,Flicoteau Rémi,Van Huyen Jean-Paul Duong,Correas Jean-Michel,Wedemeyer Heiner,Pol Stanislas,

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00134-021-06482-3.pdf

Reference5 articles.

1. Meersseman P, Blondeel J, De Vlieger G et al (2021) Secondary sclerosing cholangitis: an emerging complication in critically ill COVID-19 patients. Intensive Care Med. https://doi.org/10.1007/s00134-021-06445-8

2. Mallet V, Bock K, Mandengue PD et al (2021) Intravenous ketamine and progressive cholangiopathy in COVID-19 patients. J Hepatol 74:1243–1244. https://doi.org/10.1016/j.jhep.2021.02.007

3. Chanques G, Constantin J-M, Devlin JW et al (2020) Analgesia and sedation in patients with ARDS. Intensive Care Med 46:2342–2356. https://doi.org/10.1007/s00134-020-06307-9

4. Bütikofer S, Lenggenhager D, Garcia PDW et al (2021) Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19. Liver Int. https://doi.org/10.1111/liv.14971

5. ANSM (2017) Kétamine: risque d’atteintes hépatiques graves lors d’utilisations prolongées et/ou à doses élevées—lettre aux professionnels de santé. ANSM, France

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19-Related Cholangiopathy: Histological Findings;Diagnostics;2024-08-19

2. “Dosis sola facit venenum”—Evidence for causality in the association between ketamine and cholestatic liver injury;Hepatology International;2024-03-13

3. Distinct histopathological features of post-COVID-19 cholangiopathy;2024-03-05

4. Endoscopic Features of Post–COVID-19 Cholangiopathy and Its Management Using ERCP;American Journal of Gastroenterology;2023-12-01

5. Role of intravenous ketamine in the pathogenesis of secondary sclerosing cholangitis in critically ill patients: perpetrator or innocent bystander? Answers provided by forensic toxicology;Intensive Care Medicine;2023-11-09